News in research and innovation

Parc Taulí promotes a driving group for suicide prevention research in Catalonia
Parc Taulí promotes a driving group for suicide prevention research in Catalonia 1080 608 Oriol Capell
Under the coordination of Diego Palao, head of the mental health and neuroscience research area of ​​the I3PT and director of Mental Health of the Parc Taulí, the group promotes and integrates interdisciplinary research related to suicidal behavior and its prevention read more
Lluís Blanch, among the 5 finalists for the 2023 Sabadell Award
Lluís Blanch, among the 5 finalists for the 2023 Sabadell Award 1080 608 Oriol Capell
The award seeks to value and project the talent and milestones achieved by Sabadell personalities from very diverse disciplines throughout the year. Voting will remain open until March 14. read more
Investigating Fragile X syndrome in girls and adolescents
Investigating Fragile X syndrome in girls and adolescents 1080 608 Oriol Capell
As part of World Minority Disease Day, we are publishing the second installment of the 'Presenta la teva tesi' series. Lorena Joga, child and youth neuropsychologist at Parc Taulí and researcher at the I3PT explains what Fragile X Syndrome is and how it affects girls and teenagers. read more
The Committee on Ethics and Research with Medicines of the Parc Taulí, positioned again as the 4th in Spain
The Committee on Ethics and Research with Medicines of the Parc Taulí, positioned again as the 4th in Spain 1080 608 Oriol Capell
El Parc Taulí evaluated a total of 62 projects with clinical trials with medicines last year, which represents 7% of the total of projects of this nature evaluated throughout 2023 in the country. read more
I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome
I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome 1080 608 Mireia Córcoles
The Phase IIa study will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with FXS, the most common form of inherited intellectual disability without a specific treatment read more
Parc Taulí concludes a new edition of the Bring It innovation program
Parc Taulí concludes a new edition of the Bring It innovation program 1080 608 Oriol Capell
PHIRFAV, a project of the Parc Taulí Nephrology Service to implement artificial intelligence in the monitoring of arteriovenous fistula, has been the winner read more
Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.